Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
大脑健康的多维评估作为痴呆症风险和复原力的标志
基本信息
- 批准号:10451624
- 负责人:
- 金额:$ 192.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:African American populationAgeAgingAlzheimer&aposs DiseaseAlzheimer’s disease biomarkerAmyloidAnisotropyAuditoryAutopsyBehavioralBiological MarkersBiologyBloodBlood GlucoseBlood VesselsBrainBrain PathologyBrain imagingBrain-Derived Neurotrophic FactorChronologyClinicClinicalClinical TrialsCognitionCognitiveCohort StudiesDNA MethylationDataDementiaDevelopmentDietDiffuseDimensionsDiseaseEarly DiagnosisEducationEducational workshopElderlyEpigenetic ProcessEquilibriumEuropeanEvaluationEventFractureFramingham Heart StudyFundingGaitGeneticGenomicsGrantHearingHeartHippocampus (Brain)HispanicHispanic ancestryIGF1 geneImageImpaired cognitionIndividualInjuryItalyLifeLife StyleLipidsMagnetic Resonance ImagingMarital StatusMeasurementMeasuresMemoryMetabolicMexican AmericansMotorNeurologicNeurological statusOccupationsOsteoporosisOutcomeParticipantPathogenesisPathologyPatternPerceptionPersonsPhasePhenotypePhysical activityPlayPopulationPositron-Emission TomographyProteinsProteomicsResearchResistanceRetinaRiskRisk FactorsRisk MarkerRoleSamplingSensorySkeletonSleepSmell PerceptionSocial NetworkStrokeStructureTactileTestingTexasTherapeutic InterventionTouch sensationTransient Ischemic AttackVascular Endothelial Growth FactorsVisionVisualWaterWhite Matter Hyperintensityaging brainbaseblood-based biomarkerbone massbrain healthbrain magnetic resonance imagingcerebral atrophycirculating biomarkerscognitive functioncognitive reservecognitive testingcohortdementia riskearly detection biomarkersendophenotypeepidemiology studyexecutive functionexperiencefollow-upgenetic predictorsgenetic variantgray matterhuman old age (65+)indexinginsightmild cognitive impairmentmortalitymotor disordernervous system disordernormal agingoffspringoutcome predictionpersonalized risk predictionpre-clinicalpredictive markerpreventresiliencerisk stratificationsensorimotor systemsocialstroke outcomesulfated glycoprotein 2tau Proteinsvascular cognitive impairment and dementiavascular factor
项目摘要
Persons with similar amount of Alzheimer's or vascular brain pathology on imaging or autopsy may have had
very different clinical and functional experiences during life. One possible reason could be varying amounts of
cognitive reserve, or brain health which protects them from clinical manifestations. Thus, just as a healthy bone
mass through life protects from osteoporosis and fractures, having a healthy brain at age 65-85, a consequence
of genetic propensity and lifelong environmental, behavioral and disease-related factors, will protect from
development of AD, dementia and stroke. How do we define a healthy brain phenotype? Brain health is typically
characterized using quantitative measurements MRI and PET brain imaging, cognitive testing and at autopsy.
Other dimensions of brain health, often altered in aging, prior to cognition, include retinal structure and
vasculature, olfactory, visual, auditory, tactile and sensory perception and motor abilities. Sensory-motor
measures are promising early biomarkers of AD and may play a causal role in the development or progression
of dementia. An NIA workshop titled “Sensory and Motor dysfunctions in Aging and AD” concluded that
comprehensive sensory motor testing would provide key mechanistic insights into AD pathogenesis. We
propose to incorporate multiple such sensory-motor measures in the recently funded 10th exam for 1874
Framingham Heart Study (FHS) Offspring and Omni 1 cohort participants and develop a multi-dimensional
sensory-motor Brain Health Index (smBHI), as well as a composite BHI (cBHI) that additionally includes brain
MRI and cognitive measures. Predictors and outcomes related to the BHI will be identified using the extensive
profiling of risk factors, repeated measures of brain structure and function, information on MCI, dementia (AD
and VCID) and stroke outcomes already available in FHS. It will be validated in 3 additional population samples,
200 African- Americans in Jackson, MS, 400 Hispanic participants in San Antonio, Texas and 1650 European
ancestry participants in the Great Age Study in Barri, Italy (LOS only, will collect and analyze data with Italian
funding. Aim 1: To characterize individual brain health using a multidimensional sensory-motor `Brain Health
Index' by assessing olfaction, retina, vision, auditory function, vestibular function, touch sensation, motor
function, and examine its association with (i) cross-sectional MRI, PET and cognitive function and (ii) incident
mild cognitive impairment (MCI), dementia including AD, VCID, TIA, stroke and all-cause mortality over 3-5
years and subsequent follow-up Aim 2: To investigate the effect of lifelong (20-40+ years) social, behavioral
and vascular/metabolic factors, measured previously on these participants, on individual sensory-motor
functions, smBHI and cBHI and brain reserve (difference between BH age and chronological age) Aim 3: To
examine the association between (1) genetic, (2) putative circulating biomarkers and (3) epigenetic aging and
`brain health' Aim 4: To replicate the associations observed in Aims 1, 2 and 3 in our three replication samples.
在成像或尸检时具有相似数量的阿尔茨海默氏症或血管脑病理学的人
生活中的临床和功能经历截然不同。一个可能的原因可能是不同的
认知储备或大脑健康,可以保护它们免受临床表现。就像健康的骨头一样
通过生命的质量可防止骨质疏松和骨折,在65-85岁时具有健康的大脑,结果是
遗传倾向和终身环境,行为和疾病相关的因素将保护
AD,痴呆和中风的发展。我们如何定义健康的大脑表型?大脑健康通常是
使用定量测量值MRI和PET脑成像,认知测试和尸检表征。
在认知之前,脑部健康的其他方面通常会改变,包括残留结构和
脉管系统,嗅觉,视觉,听觉,触觉和感官感知和运动能力。感觉运动
承诺措施是AD的早期生物标志物,并可能在发展或进展中起因果作用
痴呆症。 NIA讲习班标题为“衰老和广告中的感觉和运动功能障碍”得出结论
全面的感觉运动测试将为AD发病机理提供关键的机械见解。我们
提议将多种此类感官运动量度纳入1874年最近资助的第10次考试
Framingham心脏研究(FHS)后代和Omni 1队列参与者并发展多维
感觉运动脑健康指数(SMBHI)以及还包括大脑的复合BHI(CBHI)
MRI和认知测量值。与BHI相关的预测因素和结果将使用广泛的
危险因素的分析,大脑结构和功能的重复度量,有关MCI的信息,痴呆症(AD)
和VCID)和中风成果已在FHS中提供。它将在另外3个人口样本中进行验证,
200名非裔美国人在杰克逊,MS,400名西班牙裔参与者,得克萨斯州圣安东尼奥和1650年欧洲人
意大利巴里(Barri)的伟大年龄研究的祖先参与者(仅LOS,将与意大利语收集和分析数据
资金。目的1:使用多维感觉运动```
索引'通过评估嗅觉,视网膜,视觉,听觉功能,前庭功能,触摸感,电动机
功能,并检查其与(i)横截面MRI,PET和认知功能以及(II)事件的关联
轻度认知障碍(MCI),痴呆症,包括AD,VCID,TIA,中风和全因死亡率以上3-5
年和随后的后续目标2:研究终身(20-40岁以上)社会,行为的影响
和血管/代谢因素,先前在这些参与者上,在单个感觉运动上测量
功能,SMBHI和CBHI和大脑储备(BH年龄和年代年龄之间的差异)目标3:
检查(1)遗传,(2)假定的循环生物标志物与(3)表观遗传衰老和
“大脑健康”目标4:复制在我们的三个复制样本中目标1、2和3中观察到的关联。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amir H Kashani其他文献
Amir H Kashani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amir H Kashani', 18)}}的其他基金
Functional Imaging in Hypoxic-Ischemic Retinal Disease
缺氧缺血性视网膜疾病的功能成像
- 批准号:
10456440 - 财政年份:2021
- 资助金额:
$ 192.46万 - 项目类别:
Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
多种族人群中影像学和基于血液的小血管 VCID 生物标志物的验证
- 批准号:
10611821 - 财政年份:2021
- 资助金额:
$ 192.46万 - 项目类别:
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
大脑健康的多维评估作为痴呆症风险和复原力的标志
- 批准号:
10670132 - 财政年份:2020
- 资助金额:
$ 192.46万 - 项目类别:
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
大脑健康的多维评估作为痴呆症风险和复原力的标志
- 批准号:
10261497 - 财政年份:2020
- 资助金额:
$ 192.46万 - 项目类别:
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics
使用基于 OCT 血管造影的新型指标评估视网膜血管疾病中的视网膜毛细血管密度、形态和功能
- 批准号:
10004661 - 财政年份:2019
- 资助金额:
$ 192.46万 - 项目类别:
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics
使用基于 OCT 血管造影的新型指标评估视网膜血管疾病中的视网膜毛细血管密度、形态和功能
- 批准号:
10460809 - 财政年份:2019
- 资助金额:
$ 192.46万 - 项目类别:
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics
使用基于 OCT 血管造影的新型指标评估视网膜血管疾病中的视网膜毛细血管密度、形态和功能
- 批准号:
10245006 - 财政年份:2019
- 资助金额:
$ 192.46万 - 项目类别:
3D OCT Angiography for quantitative characterization of diabetic retinopathy
3D OCT 血管造影定量表征糖尿病视网膜病变
- 批准号:
9299870 - 财政年份:2017
- 资助金额:
$ 192.46万 - 项目类别:
Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
脑小血管疾病的脑和视网膜微血管成像
- 批准号:
9356350 - 财政年份:2016
- 资助金额:
$ 192.46万 - 项目类别:
Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
多种族人群中影像学和基于血液的小血管 VCID 生物标志物的验证
- 批准号:
10369505 - 财政年份:2016
- 资助金额:
$ 192.46万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
- 批准号:
10643344 - 财政年份:2023
- 资助金额:
$ 192.46万 - 项目类别:
Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
- 批准号:
10658457 - 财政年份:2023
- 资助金额:
$ 192.46万 - 项目类别:
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations
SARS-CoV-2 感染和遗传变异的相互作用对祖先和混血人群认知能力下降和阿尔茨海默病风险的影响
- 批准号:
10628505 - 财政年份:2023
- 资助金额:
$ 192.46万 - 项目类别:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of School Segregation and Experiences of Discrimination
阿尔茨海默病和相关痴呆症的种族差异:学校隔离的作用和歧视经历
- 批准号:
10606362 - 财政年份:2023
- 资助金额:
$ 192.46万 - 项目类别:
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
糖化与祖先特异性肿瘤基质之间的因果关系
- 批准号:
10586185 - 财政年份:2023
- 资助金额:
$ 192.46万 - 项目类别: